Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
1 hedge funds and large institutions have $1K invested in Nemaura Medical, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
98% less capital invested
Capital invested by funds: $46K → $1K (-$45K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$36K |
| 2 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1K |
NMRD Hedge Fund Activity: Q4 2019 in Review
1 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q4 2019, worth a combined $1K — down 98% from $46K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NMRD and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $1.84K. The largest seller was Citadel Advisors, exiting entirely with an estimated $36K sold.
- 1 institutional investor held Nemaura Medical, Inc. Common Stock (NMRD) as of Q4 2019, down from 3 in Q3 2019.
- Funds reported $1K of Nemaura Medical, Inc. Common Stock stock for Q4 2019, down 98% quarter-over-quarter.
- 1 fund opened new Nemaura Medical, Inc. Common Stock positions in Q4 2019 and 3 closed out, a net change of -2 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q4 2019 was Deutsche Bank, an estimated $1.84K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q4 2019 was Citadel Advisors, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2019.